|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| A61K 31/7042 | (2006.01) | ||
| A61K 31/7052 | (2006.01) | ||
| A61K 31/7056 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| C07H 19/052 | (2006.01) |
| (11) | Patento numeris | 1070078 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 99919169.5 |
| Europos patento paraiškos padavimo data | 1999-04-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2001-01-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2003-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP9902/213 |
| Data | 1999-04-01 |
| (87) | Numeris | WO 9905/1617 |
| Data | 1999-10-14 |
| (30) | Numeris | Data | Šalis |
| 9807355 | 1998-04-07 | GB |
| (72) |
CARTER, Barry, Howard, US
HODGSON, Anne, GB
HUANG, Lian-Feng, US
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE |
| FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-BETA-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE |